We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+5.8%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$61.1M
AUM Growth
-$266K
Cap. Flow
-$9.61M
Cap. Flow %
-15.72%
Top 10 Hldgs %
31.78%
Holding
108
New
30
Increased
19
Reduced
22
Closed
32

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$1.88M
2
AET
Aetna Inc
AET
+$1.8M
3
BAX icon
Baxter International
BAX
+$1.22M
4
MCK icon
McKesson
MCK
+$1.04M
5
UNH icon
UnitedHealth
UNH
+$1.03M

Top Sells

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$2.28M
2
AGN
Allergan plc
AGN
+$1.83M
3
BMY icon
Bristol-Myers Squibb
BMY
+$1.81M
4
AAPL icon
Apple
AAPL
+$1.65M
5
GILD icon
Gilead Sciences
GILD
+$1.6M

Sector Composition

Rank Sector Weight
1 Healthcare 45.99%
2 Miscellaneous 26.89%
3 Technology 8.54%
4 Communication Services 4.28%
5 Financials 4.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
1
PUT
Merck
MRK
$366B
$2.5M 4.09%
+45,483
New +$2.42M
BMY icon
2
CALL
Bristol-Myers Squibb
BMY
$136B
$2.4M 3.92%
32,600
+900
+3% +$63.6K
AET
3
DELISTED
Aetna Inc
AET
$2.28M 3.72%
18,640
+15,649
+523% +$1.8M
EW icon
4
Edwards Lifesciences
EW
$52B
$2.26M 3.7%
68,049
+6,087
+10% +$208K
ALDR
5
DELISTED
Alder Biopharmaceuticals
ALDR
$1.87M 3.06%
75,002
+5,260
+8% +$142K
BIIB icon
6
Biogen
BIIB
$32.3B
$1.73M 2.82%
+7,139
New +$1.88M
MDCO
7
DELISTED
Medicines Co
MDCO
$1.71M 2.8%
50,808
+4,470
+10% +$158K
LLY icon
8
PUT
Eli Lilly
LLY
$1.05T
$1.6M 2.62%
+20,300
New +$1.53M
META icon
9
Meta Platforms (Facebook)
META
$1.47T
$1.55M 2.54%
13,595
+7,668
+129% +$884K
AMAT icon
10
Applied Materials
AMAT
$366B
$1.53M 2.5%
63,793
+36,557
+134% +$806K
WBA
11
DELISTED
Walgreens Boots Alliance
WBA
$1.48M 2.41%
17,725
-8,304
-32% -$670K
JAZZ icon
12
Jazz Pharmaceuticals
JAZZ
$15.9B
$1.44M 2.36%
10,209
-5,127
-33% -$756K
ABBV icon
13
AbbVie
ABBV
$451B
$1.44M 2.35%
23,814
-22,215
-48% -$1.35M
XLV icon
14
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$44.5B
$1.33M 2.17%
+18,500
New +$1.3M
BAX icon
15
Baxter International
BAX
$13.5B
$1.26M 2.06%
+27,804
New +$1.22M
MCK icon
16
McKesson
MCK
$104B
$1.11M 1.81%
+5,929
New +$1.04M
UNH icon
17
UnitedHealth
UNH
$353B
$1.09M 1.79%
+7,747
New +$1.03M
AMZN icon
18
Amazon
AMZN
$2.87T
$1.08M 1.77%
30,280
-13,880
-31% -$469K
QQQ icon
19
CALL
Invesco QQQ Trust
QQQ
$489B
$1.07M 1.76%
+10,000
New +$1.08M
DISH
20
DELISTED
DISH Network Corp.
DISH
$1.06M 1.74%
+20,246
New +$989K
BKD icon
21
Brookdale Senior Living
BKD
$2.8B
$1.05M 1.71%
67,761
+22,930
+51% +$400K
HCA icon
22
HCA Healthcare
HCA
$90.5B
$1.05M 1.71%
13,578
-28,866
-68% -$2.28M
AMAT icon
23
CALL
Applied Materials
AMAT
$366B
$976K 1.6%
+40,700
New +$898K
XLB icon
24
CALL
State Street Materials Select Sector SPDR ETF
XLB
$8.81B
$976K 1.6%
+28,600
New +$666K
BMRN icon
25
BioMarin Pharmaceuticals
BMRN
$12.5B
$914K 1.5%
+11,752
New +$999K
1
2 3 4 5

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q2 2016 Portfolio in Review

As of Q2 2016, Partner Investment Management held 108 positions worth $61.1M, down 0.43% from $61.4M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Partner Investment Management withdrew a net $9.61M in Q2 2016, closing 32 positions and reducing 22 holdings. Its most notable exit was Allergan plc, an estimated $1.83M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, down from 52% a quarter earlier, followed by Miscellaneous and Technology.

Against the trend, Partner Investment Management opened a new position in Biogen worth $1.73M.

  • Partner Investment Management's largest Q2 2016 buy was Biogen: 7,139 shares worth $1.73M.
  • Partner Investment Management added most to Aetna Inc in Q2 2016, an estimated $1.8M increase.
  • Partner Investment Management's biggest Q2 2016 reduction was HCA Healthcare, cutting an estimated $2.28M.
  • Partner Investment Management fully exited Allergan plc in Q2 2016, selling an estimated $1.83M.
  • Partner Investment Management's ten largest holdings make up 32% of its $61.1M portfolio in Q2 2016.
  • Partner Investment Management opened 30 new positions and closed 32 in Q2 2016.
  • Partner Investment Management's portfolio value fell 0.43% quarter-over-quarter to $61.1M.

Based on Partner Investment Management's 13F filing for Q2 2016, filed 15 Aug 2016.